PAZZAGLI, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 11.593
EU - Europa 7.734
AS - Asia 3.401
SA - Sud America 485
AF - Africa 104
OC - Oceania 90
Continente sconosciuto - Info sul continente non disponibili 4
Totale 23.411
Nazione #
US - Stati Uniti d'America 11.530
PL - Polonia 2.413
RU - Federazione Russa 2.282
SG - Singapore 1.049
HK - Hong Kong 771
IT - Italia 685
CN - Cina 595
IE - Irlanda 581
SE - Svezia 550
BR - Brasile 408
KR - Corea 389
DE - Germania 302
UA - Ucraina 296
FI - Finlandia 209
VN - Vietnam 141
IN - India 139
GB - Regno Unito 117
CH - Svizzera 106
JO - Giordania 92
AU - Australia 89
FR - Francia 71
TR - Turchia 53
CI - Costa d'Avorio 44
ID - Indonesia 38
JP - Giappone 34
NL - Olanda 33
CA - Canada 30
ES - Italia 28
AR - Argentina 26
BD - Bangladesh 21
IQ - Iraq 19
MX - Messico 17
ZA - Sudafrica 17
AT - Austria 16
EC - Ecuador 16
BE - Belgio 14
SC - Seychelles 12
VE - Venezuela 11
UZ - Uzbekistan 10
AZ - Azerbaigian 9
MA - Marocco 9
BG - Bulgaria 7
CO - Colombia 6
KE - Kenya 6
PY - Paraguay 6
SA - Arabia Saudita 6
CZ - Repubblica Ceca 4
EU - Europa 4
OM - Oman 4
PA - Panama 4
PE - Perù 4
PK - Pakistan 4
RO - Romania 4
UY - Uruguay 4
AL - Albania 3
IL - Israele 3
LK - Sri Lanka 3
LT - Lituania 3
PH - Filippine 3
TN - Tunisia 3
BJ - Benin 2
BO - Bolivia 2
CL - Cile 2
DZ - Algeria 2
EG - Egitto 2
GD - Grenada 2
HN - Honduras 2
IR - Iran 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
LV - Lettonia 2
MM - Myanmar 2
MU - Mauritius 2
NI - Nicaragua 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
CG - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MY - Malesia 1
NE - Niger 1
PS - Palestinian Territory 1
PW - Palau 1
RE - Reunion 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TJ - Tagikistan 1
UG - Uganda 1
Totale 23.411
Città #
Warsaw 2.411
Santa Clara 2.021
Fairfield 1.330
Ashburn 939
Chandler 655
Woodbridge 643
Hong Kong 635
Singapore 630
Dublin 580
Seattle 579
Cambridge 522
Houston 467
Wilmington 464
Jacksonville 457
Seoul 388
Ann Arbor 215
Beijing 213
Altamura 204
Lawrence 196
Dallas 195
Princeton 184
Buffalo 178
Florence 178
Los Angeles 142
Boardman 128
Boston 121
Hefei 100
Bern 98
Melbourne 89
San Diego 85
Munich 81
Mumbai 80
Medford 74
New York 74
Moscow 64
Shanghai 59
Falls Church 57
Abidjan 44
Kent 42
Ho Chi Minh City 41
Dong Ket 40
Norwalk 40
Izmir 37
Milan 35
Turku 34
San Jose 32
The Dalles 32
Tokyo 32
Jakarta 29
São Paulo 29
Bremen 28
Clifton 28
Paris 28
Pune 26
Andover 23
Auburn Hills 22
Phoenix 22
Hanoi 21
Redondo Beach 21
Helsinki 20
Yubileyny 19
Hillsboro 18
Toronto 15
Vienna 15
Rio de Janeiro 14
Brussels 13
Brooklyn 12
Frankfurt Am Main 12
London 12
Stockholm 12
Verona 12
West Jordan 12
Redwood City 11
Rome 11
Barcelona 10
Chennai 10
Chicago 10
Johannesburg 10
Atlanta 9
Baku 9
Tashkent 9
Belo Horizonte 8
Guayaquil 8
Bondeno 7
Brasília 7
Haiphong 7
Mexico City 7
Salvador 7
Sofia 7
Tianjin 7
Amsterdam 6
Brescia 6
Council Bluffs 6
Dearborn 6
Denver 6
Geneva 6
Guangzhou 6
Guarulhos 6
Istanbul 6
Old Bridge 6
Totale 16.622
Nome #
Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers 357
Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions 343
A high-resolution melting protocol for rapid and accurate differential diagnosis of thyroid nodules. 340
Genetic and epigenetic factors in regulation of microRNA in colorectal cancers 339
Circulating BRAFV600E in the diagnosis and follow-up of differentiated papillary thyroid carcinoma. 312
Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. 302
Multiparametric analysis of cell-free DNA in melanoma patients. 293
Multidrug resistance in ovarian cancer: comparing an immunocytochemical study and ATP-tumor chemosensitivity assay. 288
Influence of 17q gain and promoter polymorphisms on mRNA expression of somatostatin receptor type 2 in neuroblastoma. 284
High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer. 277
NEW INSIGHTS IN THE CLINICAL AND TRANSLATIONAL RELEVANCE OF miR483-5p IN ADRENOCORTICAL CANCER 274
Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR. 270
Feasibility of a workflow for the molecular characterization of single cells by next generation sequencing 267
Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer 267
Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. 264
SPIDIA-DNA: an External Quality Assessment for the pre-analytical phase of blood samples used for DNA-based analyses. 253
SPIDIA-RNA: second external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses. 250
Current landscape and new paradigms of proficiency testing and external quality assessment for molecular genetics 243
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. 214
Application of a filtration and isolation by size technique for the detection of circulating tumor cells in cutaneous melanoma. 206
null 196
Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma 195
Allele specific Taqman–based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients. 191
An Italian Program of External Quality Control for Quantitative Assays Based on Real-Time PCR with Taq-Man Probes. 190
The genes that codify angiotensin converting enzyme and type 1 receptor for angiotensin II have a different effect on longevity 186
A real-time quantitative PCR assay for the detection of Sphaeropsis sapinea from inoculated Pinus nigra shoots 184
Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study 175
Glycated hemoglobin (HbA1c) measurement in frozen whole blood depends on baseline values of fresh samples. 173
DETECTION OF CIRCULATING TUMOR CELLS IN PATIENTS WITH ADRENOCORTICAL CARCINOMA: A MONOCENTRIC PRELIMINARY STUDY. 173
Genetic and epigenetic factors in regulation of microRNA in colorectal cancers 172
Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study 171
Adenosine triphosphate release by osmotic shock and hemoglobin A1C in diabetic subjects' erythrocytes. 169
The glycopeptide csf114(glc) detects serum antibodies in multiple sclerosis. 169
Centenarians in Tuscany: The role of the environmental factors. 169
Age-related changes in serum total antioxidant capacity (TAC), dehydroepiandrosterone sulphate (DHEAS) and insulin-like growth factor-1 (IGF-1): evidence in healthy centenarian subjects. 167
Red or white wine assumption and serum antioxidant capacity. 166
Circulating Tumor Cells Detection and Counting in Uveal Melanomas by a Filtration-Based Method 165
SPIDIA-RNA: First external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses. 164
Combining qualitative and quantitative imaging evaluation for the assessment of genomic DNA integrity: The SPIDIA experience 164
Circulating tumour cells in colorectal cancer 163
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 163
The pre-analytical phase of the liquid biopsy 163
Real-time PCR detection of Biscogniauxia mediterranea in symptomless oak tissue 162
Measurement of steroids in human plasma and tissues by isotope dilution mass spectrometry. 162
Quantitative RT-PCR assay for VEGF mRNA in human tumors of the kidney. 162
Circulating cell-free DNA in cancer 162
Urinary carbonic anhydrase IX splicing messenger RNA variants in urogenital cancers 162
luciferase gene as reporter: comparison with CAT gene and use in transfection and microinjection of mammalian cells 159
Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide. 159
Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer. 157
Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome. 156
Age-related secretion of androstenedione, testosterone and dihydrotestosterone by the human testis. 156
Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma. 154
NUCLEOSIDE ANALOGUES AS RADIOSENSITIZERS IN THE TREATMENT OF LUNG CANCER 153
Implementation of a proficiency testing for the assessment of the preanalytical phase of blood samples used for RNA based analysis. 153
BRAFV600E detection in melanoma is highlyimproved by COLD-PCR. 153
Tankyrase, a positive regulator of telomere elongation, is over expressed in human breast cancer. 151
Comparison of pre- and postsurgical concentrations of blood HER-2 mRNA and HER-2 extracellular domain reflects HER-2 status in early breast cancer 149
Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue 149
GENE AMPLIFICATION FOR c-erbB-2, c-myc, epidermal growth factor receptor, int-2 and N-myc MEASURED BY QUANTITATIVE PCR WITH A MULTIPLE COMPETITOR TEMPLATE. 149
Implementation of a companion diagnostic in the clinical laboratory: The BRAF example in melanoma 148
Detection of Diplodia pinea in asymptomatic pine shoots and its relation to the Normalized Insolation index 148
Circulating benign nevus cells detected by ISET technique: warning for melanoma molecular diagnosis. 148
Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. 146
Analysis of 12q13-15 genes in parosteal osteosarcoma 146
A solid phase chemiluminescent immunoassay (LIA) for testosterone glicuronide in diluted urines. 145
Healthy centenarian subjects as living model of "successful aging": A study on fasting glycemia, C-peptide, dehydroepiandrosterone sulphate (DHEAS) and insulin-like growth factor (IGF-1). 144
Rapid, quantitative nonisoptopic assay for telomerase activity in human tumors 143
Evaluation of the liquid biopsy for the detection of brafv600e mutation in metastatic melanoma patients 143
Laser microdissection on Norway spruce bark tissue: A suitable protocol for subsequent real-time reverse transcription–polymerase chain reaction (RT-PCR) analysis 142
Longevity index (LI%) and centenarity index (CI%): New indicators to evaluate the characteristics of aging process in the Italian population. 142
Telomerase in urological malignancy 141
Biological parameters for the choice of antiangiogenic therapy and efficacy monitoring 141
Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection. 139
Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe 139
Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction. 139
Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique 138
Comparison of pre- and postsurgical concentrations of blood HER-2 mRNA and HER-2 extracellular domain reflects HER-2 status in early breast cancer. 137
Improvement of technical and analytical performance in DNA sequencing by external quality assessment-based molecular training. 137
Effects of gemcitabine in normal and transformed human lung cell cultures: citotoxicity and increase of radiation sensitivity 137
EQUAL-qual: a European program for external quality assessment of genomic DNA extraction and PCR amplification. 137
Genetic and epigenetic factors in regulation of microRNA in colorectal cancers. 136
Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients 136
Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay. 135
Melting temperature analysis as quantitative method for detection of point mutations. 132
An assay procedure for plasma progesterone based on antibody-enhanced chemiluminescence. 132
Methodologic European external quality assurance for DNA sequencing: the EQUALseq program. 131
Effect of diet and red wine consumption on serum total antioxidant capacity (TAC), dehydroepiandrosterone-sulphate (DHEAS) and insulin-like growth factor-1 (IGF-1) in Italian centenarians. 131
Healthy centenarian subjects: the effect of red wine consumption on liver function tests. 131
The meat in the diet of aged subjects and the antioxidant effects of carnosine. 126
Influence of pre-analytical procedures on genomic DNA integrity in blood samples: the SPIDIA experience 124
Influence of storage conditions and extraction methods on the quantity and quality of circulating cell-free DNA (ccfDNA): the SPIDIA-DNAplas External Quality Assessment experience 122
An immunoassay for plasma cortisol based on chemiluminescence. 121
Studio prospettico sul carcinoma del colon e angiogenesi: risultati preliminari 120
QUANTITATIVE POLYMERASE CHAIN REACTION-BASED HOMOGENEOUS ASSAY WITH FLUOROGENIC PROBES TO MEASURE C-ERBb-2 ONCOGENE AMPLIFICATION. 120
Circulating nucleic acids in cancer and pregnancy 120
Tyrosinase mRNA levels in the blood ofuveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression. 119
Measuring c-erbB-2 oncogene amplification in fresh and paraffin-embedded tumors by competitive polymerase chain reaction 119
ATP chemosensitivity testing: methodology and comparison with other methods 118
Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas 118
Totale 17.650
Categoria #
all - tutte 62.386
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.386


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.234 0 0 0 0 0 270 79 173 188 248 121 155
2021/20221.160 30 80 79 40 77 81 50 60 76 62 198 327
2022/20232.943 295 557 87 253 243 501 349 155 280 18 73 132
2023/2024967 50 119 168 50 61 140 43 196 15 28 66 31
2024/20256.154 199 660 376 1.013 1.868 666 99 424 302 160 214 173
2025/20263.543 759 928 518 503 815 20 0 0 0 0 0 0
Totale 23.559